Bioprocess Bags Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (2D Bioprocess Bags, 3D Bioprocess Bags, Other Bags & Accessories), By Workflow (Upstream Process, Downstream Process, Process Development), by End User (Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs, Academic & Research Institutes), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.57 Billion
CAGR (2026-2031)	14.18%
Fastest Growing Segment	Downstream Process
Largest Market	North America
Market Size (2031)	USD 7.91 Billion

Market Overview

The Global Bioprocess Bags Market will grow from USD 3.57 Billion in 2025 to USD 7.91 Billion by 2031 at a 14.18% CAGR. Bioprocess bags are sterile, single-use containment systems manufactured from medical-grade polymeric films, designed to securely hold, transport, and process biopharmaceutical fluids such as media, buffers, and harvested cell cultures. The global market is primarily supported by the critical need to eliminate cross-contamination risks inherent in reusable stainless-steel equipment, thereby ensuring patient safety during manufacturing. Additionally, the substantial reduction in cleaning validation expenses and the operational flexibility required to accelerate facility turnaround times serve as distinct economic drivers fostering widespread commercial adoption.

One significant challenge impeding market expansion is the strict regulatory scrutiny regarding leachables and extractables, where chemical compounds from the plastic film may migrate into the drug product and compromise stability. This technical hurdle necessitates rigorous validation testing which can delay implementation. According to the European Federation of Pharmaceutical Industries and Associations, in 2024, the industry invested approximately €55 billion in research and development in Europe, a massive financial commitment that underscores the critical necessity for reliable, compliant single-use consumables to support these expanding biologics pipelines.

Key Market Drivers

The surging global demand for biologics, vaccines, and biosimilars acts as a primary catalyst for the bioprocess bags market, necessitating manufacturing solutions that ensure sterility and speed. As pharmaceutical companies accelerate their development pipelines to address chronic diseases, the reliance on single-use containment systems to manage complex fluids has intensified. This trend is underscored by robust regulatory activity; according to the U.S. Food and Drug Administration, in January 2025, the agency's Center for Drug Evaluation and Research approved 18 new biologic entities in 2024, reflecting a sustained influx of large-molecule therapies entering the commercial space. To meet this growing production requirement, the consumption of single-use technologies has remained substantial across the supply chain. Highlighting the scale of this demand, according to Sartorius, in February 2025, the company's Bioprocess Solutions Division reported sales revenue of approximately €2.7 billion for the 2024 fiscal year, confirming the critical role of these consumables in modern biomanufacturing.

Concurrently, the rapid expansion of the cell and gene therapy (CGT) manufacturing sector is creating a distinct, high-value niche for bioprocess bags. Unlike traditional biologics, these therapies often require patient-specific processing where cross-contamination risks must be eliminated, making single-use bags indispensable for secure fluid handling and cryopreservation. The sector's commercial maturity is advancing, supported by renewed financial confidence that fuels manufacturing scale-up. According to the Alliance for Regenerative Medicine, in January 2025, the global sector experienced a 30% increase in investment activity, a financial momentum that directly supports the build-out of specialized facilities reliant on sterile, disposable containment solutions.

Download Free Sample Report

Key Market Challenges

Strict regulatory scrutiny regarding leachables and extractables presents a formidable challenge that significantly hampers the growth of the Global Bioprocess Bags Market. Since these single-use containment systems are constructed from polymeric films, there is an inherent risk that chemical compounds may migrate into the biopharmaceutical fluids, potentially compromising the safety and stability of the drug product. This technical vulnerability necessitates rigorous, time-consuming, and expensive validation testing to demonstrate compliance with evolving safety standards, which creates substantial delays in the implementation of these technologies. Pharmaceutical manufacturers are consequently forced to dedicate extensive resources to material qualification, increasing the total cost of ownership and causing hesitation in transitioning from established stainless-steel equipment. This regulatory burden is a verified constraint on industry progress; according to the International Society for Pharmaceutical Engineering (ISPE), in 2024, nearly half of the industry professionals surveyed cited complex regulatory challenges as the most significant barrier impeding the adoption of innovative manufacturing technologies. This prevailing uncertainty regarding compliance requirements directly limits the operational flexibility of manufacturers and restricts the widespread commercial scaling of bioprocess bag systems for sensitive biologic applications.

Key Market Trends

The Development of Sustainable and Bio-Based Film Materials is rapidly reshaping the market as biopharmaceutical companies prioritize the reduction of Scope 3 greenhouse gas emissions. Suppliers are increasingly re-engineering standard polyethylene films using renewable feedstocks to lower product carbon footprints while maintaining the rigorous sterility and barrier performance required for drug substance storage. This transition is driven by the industry's commitment to circular economy principles and the need to mitigate the environmental impact of disposable consumables. Demonstrating this material innovation, according to Thermo Fisher Scientific, June 2024, in the 'Thermo Fisher Scientific Introduces Biobased Solutions' press release, the company launched ISCC PLUS-certified biobased films for single-use bioprocessing containers that allow manufacturers to eliminate carbon emissions specifically related to the plastic resin.

Concurrently, the Integration of Single-Use Sensors for Real-Time Monitoring is transforming bioprocess bags from passive storage units into intelligent analytical components. This trend is fueled by the move toward Process Analytical Technology (PAT), where embedded sensors for pH, dissolved oxygen, and metabolites enable continuous data acquisition without the contamination risks associated with manual sampling. These smart systems are essential for closing the loop in automated fluid management, thereby enhancing process control and consistency. Highlighting this digital shift, according to Rockwell Automation, August 2024, in the 'State of Smart Manufacturing Report: Life Sciences Edition', 96% of life sciences manufacturers indicated they were using or evaluating smart manufacturing technologies, underscoring the widespread adoption of such digitized solutions.

Segmental Insights

The Downstream Process segment currently represents the fastest-growing category within the global bioprocess bags market. This rapid expansion is primarily driven by the critical necessity for efficient product recovery and purification in biopharmaceutical manufacturing. Manufacturers are increasingly adopting single-use bags during filtration and separation stages to eliminate complex cleaning validation requirements and significantly mitigate cross-contamination risks. Furthermore, stringent sterility mandates from regulatory authorities, such as the FDA, compel companies to utilize disposable containment solutions for final product handling. Consequently, the demand for high-integrity bags in purification workflows continues to accelerate.

Regional Insights

North America holds a dominant position in the global bioprocess bags market, driven by its established pharmaceutical infrastructure and substantial investments in biologics research and development. The region benefits from a high concentration of major biotechnology firms and a robust manufacturing ecosystem. Additionally, clear regulatory guidelines from the United States Food and Drug Administration support the adoption of single-use technologies to ensure product safety and compliance. This alignment of industrial capacity with favorable regulatory standards secures the region's leading status in the global sector.

Recent Developments

• In June 2025, Sartorius Stedim Biotech announced the completion of a major capacity expansion at its headquarters in Aubagne, France, significantly boosting its manufacturing capabilities for the Global Bioprocess Bags Market. The project involved doubling the cleanroom space to approximately 9,000 square meters and installing automated production lines for 2D and 3D single-use bags. These facilities are designed to meet the increasing demand for fluid management technologies used in cell culture, storage, and shipping. The CEO of Sartorius Stedim Biotech highlighted that these investments in automation and innovation would ensure the company remains competitive and ready to support the evolving needs of the biopharmaceutical industry.
• In September 2024, the Life Science business of Merck launched the Mobius ADC Reactor, a single-use mixer specifically engineered for the manufacturing of antibody-drug conjugates (ADCs). This system incorporates the company's proprietary Ultimus Film technology in its single-use bag assemblies, which provides enhanced strength and leak resistance critical for handling potent compounds. This launch expands the Global Bioprocess Bags Market by offering a specialized solution that replaces traditional stainless steel or glass reactors, thereby improving efficiency and reducing cross-contamination risks. The Head of Process Solutions at Merck noted that this development leverages their extensive experience in single-use technologies to support the safer and faster production of critical therapies.
• In September 2024, Watson-Marlow Fluid Technology Solutions launched WMArchitect, a comprehensive range of single-use fluid management solutions that includes custom and standard single-use assemblies. This platform integrates single-use bags, tubing, and connectors to streamline process development and clinical trials for biopharmaceutical companies. By providing pre-assembled and validated units, the company addresses the demand within the Global Bioprocess Bags Market for secure supply chains and regulatory compliance. The Divisional Director for Asia-Pacific remarked that these solutions are designed to prioritize customer needs through open-architecture designs that facilitate flexibility and scalability in bioprocessing operations.
• In June 2024, Thermo Fisher Scientific introduced a new line of biobased films for its single-use bioprocessing containers (BPCs), directly addressing sustainability trends in the Global Bioprocess Bags Market. These films utilize plant-based materials rather than fossil-fuel-derived resins, which allows biopharmaceutical manufacturers to reduce the carbon footprint of their operations. The biobased films were designed to maintain the same physical and chemical performance as the company’s existing film technologies, ensuring that customers can adopt them without extensive re-validation. The President of the company's single-use technologies business stated that this innovation enables manufacturers to advance their sustainability goals while maintaining productivity and accelerating the delivery of therapies.

Key Market Players

• Meissner Filtration Products, Inc.
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher Corporation
• Merck KGaA
• Compagnie de Saint-Gobain S.A
• Corning Incorporated
• Entegris Inc.
• PROAnalytics, LLC
• CellBios Healthcare and Lifesciences Pvt Ltd.

By Type	By Workflow	By Region
2D Bioprocess Bags 3D Bioprocess Bags Other Bags & Accessories	Upstream Process Downstream Process Process Development	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Bioprocess Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Bioprocess Bags Market, By Type:

• 2D Bioprocess Bags
• 3D Bioprocess Bags
• Other Bags & Accessories

• Bioprocess Bags Market, By Workflow:

• Upstream Process
• Downstream Process
• Process Development

• Bioprocess Bags Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE